Altheome
Altheome is a London-based biomarker CRO delivering MSD immunoassay services with rapid turnaround, high-quality data, and responsive customer service.
We partner with pharma, biotech, and academic groups across the full research lifecycle — from biomarker discovery and preclinical studies through clinical translation. Our MSD capabilities span the assay portfolio, including V-PLEX, U-PLEX, S-PLEX, and R-PLEX panels, across inflammation, immuno-oncology, neurodegeneration, cardiometabolic disease, and infectious disease. We run both catalogue assays and develop custom multiplex panels for novel targets.
Quality is built into how we operate: we are GCP-compliant and run our laboratory to the principles of GLP and ISO 15189, with rigorous method validation, fit-for-purpose qualification, and comprehensive QC workflows behind every dataset. Sponsors work directly with our scientific team from study design through data interpretation, with the rapid turnaround and hands-on responsiveness that's harder to find at larger generalist CROs.
Website:
https://www.altheome.com/
Contact:
Info@altheome.com
Country:
United States, United Kingdom, Germany, Canada, France, Switzerland, Sweden, Denmark, Czech Republic, Finland, Greece, Greenland, Hungary, Iceland, Ireland, Italy, Israel, Liechtenstein, Luxembourg, Mexico, Monaco, Norway, Poland, Portugal, Puerto Rico, Slovenia, Spain, The Netherlands, United Arab Emirates, Saudi Arabia, Qatar